Pediatric Bioscience, Inc.
PBI has a simple, patented blood test that facilitates much earlier diagnosis & treatment of autism, resulting in better outcomes & lower cost of care.
Pediatric Bioscience is a clinical diagnostic service company focused on commercializing novel biomarkers for the diagnosis of autism. Our first product, the MAR test, has been shown in clinical trials to be >98% specific for autism. Physicians will test high risk women prior to conception to determine their autism risk, or women with a young children to quickly “rule in” autism, resulting in earlier treatment intervention and better outcomes.